No Data
What Sino Biological,Inc.'s (SZSE:301047) P/E Is Not Telling You
Yi Qiao Shen Zhou (301047.SZ): This period has repurchased 1.24% of the shares.
On September 3, Gelonhui reported that as of August 31, 2024, the company used its own funds to repurchase shares through a dedicated securities account for centralized auction trading, with a cumulative repurchase of 1,566,420 shares, accounting for 1.24% of the company's total share capital. The highest fill price was RMB 57.59 per share, the lowest fill price was RMB 53.55 per share, and the total fill amount was RMB 87.1394 million (excluding transaction costs).
Yiqiao Shenzhou (301047.SZ): 70.73659 million shares of pre-IPO issued shares will be unlocked on August 16th.
On August 13th, GeLongHui reported that there were a total of 8 shareholders whose shares were unlocked, and the number of shares unlocked was 70.73659 million, accounting for 56.06% of the company's total shares. The lock-up period promised during the IPO was 36 months from the first day of the IPO. The date of the shares becoming tradable is Friday, August 16th, 2024.
Sino Biological Inc.: Half-year report for the year 2024.
Sino Biological Inc.: Summary of Half-Year Report in 2024.
Yiqiao Shenzhou (301047.SZ): The net income attributable to the parent in the first half of the year was 70.9406 million yuan, a year-on-year decrease of 47.71%.
On August 9th, Gelonhui reported on the 2024 semi-annual report of Yiqiao Shenzhou (301047.SZ). During the reporting period, the company achieved revenue of 0.306 billion yuan, a year-on-year increase of 4.54%. Among them, normal business revenue was 0.264 billion yuan, a year-on-year increase of 12.95%. Non-conventional businesses were affected by external factors such as market demand, achieving revenue of 27.5222 million yuan, a year-on-year decrease of 52.76%. Net income attributable to shareholders of the listed company was 70.9406 million yuan, a year-on-year decrease of 47.71%, while net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 2.0.
Are Poor Financial Prospects Dragging Down Sino Biological,Inc. (SZSE:301047 Stock?No Data
No Data
